Sham Invoices Allegedly Rewrote the Economic RealityAccording to the United States Department of Justice account of the Brian Rowan indictment, Rowan and his alleged co-conspirators issued sales invoices showing amounts that exceeded what providers actually paid for the company’s wound allografts. Shell Accounts Allegedly Added Another LayerThe indictment further alleges that Rowan and his co-conspirators used pass-through bank accounts associated with a shell company to funnel illegal kickbacks and bribes toward providers in exchange for purchasing the company’s expensive amniotic wound allografts. Prosecutors may therefore reconstruct individual transactions from beginning to end, following product shipment, invoicing, provider payment, claim submission, insurer reimbursement, rebate calculation, shell-company transfer, provider receipt, and any resulting commission or executive compensation. The Court Will Decide Whether Concealment Was IntentionalProsecutors must prove that the disputed invoices, rebates, shell-company accounts, provider payments, and reimbursement submissions formed a knowing criminal scheme rather than disconnected administrative errors, lawful discounts, genuine service arrangements, or legitimate commercial disagreements. The prosecution will likely argue that the methods’ combined design demonstrates intent because inflated invoices allegedly increased reimbursement while pass-through accounts returned concealed benefits toward providers purchasing the same company’s products.